Herbst RS - Search Results

1

Phase II study of vinorelbine and docetaxel in the treatment of advanced non-small-cell lung cancer as frontline and second-line therapy.

William WN Jr, Khuri FR, Fossella FV, Glisson BS, Zinner RG, Lee JJ, Herbst RS, Lippman SM, Kim ES. William WN Jr, et al. Among authors: herbst rs. Am J Clin Oncol. 2010 Apr;33(2):148-52. doi: 10.1097/COC.0b013e318199fb99. Am J Clin Oncol. 2010. PMID: 19687727 Free PMC article. Clinical Trial.

2

Chemotherapy for advanced non-small cell lung cancer.

Herbst RS, Dang NH, Skarin AT. Herbst RS, et al. Hematol Oncol Clin North Am. 1997 Jun;11(3):473-517. doi: 10.1016/s0889-8588(05)70445-7. Hematol Oncol Clin North Am. 1997. PMID: 9209907 Review.

3

Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer.

Herbst RS, Lilenbaum R. Herbst RS, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):67-70; discussion 71-2. Semin Oncol. 1999. PMID: 10585011 Review.

4

Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.

Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK, Fidler IJ. Herbst RS, et al. Clin Cancer Res. 2000 Mar;6(3):790-7. Clin Cancer Res. 2000. PMID: 10741698

5

Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.

Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, Ellis LM, Fidler IJ. Yano S, et al. Among authors: herbst rs. Am J Pathol. 2000 Dec;157(6):1893-903. doi: 10.1016/S0002-9440(10)64828-6. Am J Pathol. 2000. PMID: 11106562 Free PMC article.

6

9:00-9:15. Antiangiogenic Treatment with Endostatin Results in Uncoupling of Blood Flow and Glucose Metabolism in Human Tumors.

Mullani N, Herbst R, Abbruzzese J, Charnsangavej C, Kim E, Tran H, Barron B, Lamki L, Gould K. Mullani N, et al. Clin Positron Imaging. 2000 Jul;3(4):151. doi: 10.1016/s1095-0397(00)00063-7. Clin Positron Imaging. 2000. PMID: 11150754

7

9:30-9:45. First Pass FDG Measured Blood Flow in Tumors: A Comparison with O-15 Labeled Water Measured Blood Flow.

Mullani N, Herbst R, Abbruzzese J, Barron B, Lamki L, Charnsangavej C, Kim E, Tran H, Jiwani A, Gould K. Mullani N, et al. Clin Positron Imaging. 2000 Jul;3(4):153. doi: 10.1016/s1095-0397(00)00065-0. Clin Positron Imaging. 2000. PMID: 11150756

8

Clinical studies of angiogenesis inhibitors: the University of Texas MD Anderson Center Trial of Human Endostatin.

Herbst RS, Lee AT, Tran HT, Abbruzzese JL. Herbst RS, et al. Curr Oncol Rep. 2001 Mar;3(2):131-40. doi: 10.1007/s11912-001-0013-8. Curr Oncol Rep. 2001. PMID: 11177745

9

Emerging therapies in non-small-cell lung cancer.

Khuri FR, Herbst RS, Fossella FV. Khuri FR, et al. Among authors: herbst rs. Ann Oncol. 2001 Jun;12(6):739-44. doi: 10.1023/a:1011197500223. Ann Oncol. 2001. PMID: 11484947 Free article. Review.

10

Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.

Herbst RS, Lynch C, Vasconcelles M, Teicher BA, Strauss G, Elias A, Anderson I, Zacarola P, Dang NH, Leong T, Salgia R, Skarin AT. Herbst RS, et al. Cancer Chemother Pharmacol. 2001 Aug;48(2):151-9. doi: 10.1007/s002800100282. Cancer Chemother Pharmacol. 2001. PMID: 11561781 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters